Sponsor
Dr Reddy's receives two USFDA observations for New York API facility
Posted
Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Texas floods: Texas hit with another round of heavy rain; ‘code red’ issued in Kerr County
Texas is grappling with renewed heavy rains and flash flooding, just days after a devastating...